Yukino Oshima

ORCID: 0009-0003-3913-6204
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Stress, Anesthesia, and Immune Response
  • Congenital Heart Disease Studies
  • Anesthesia and Neurotoxicity Research
  • Pulmonary Hypertension Research and Treatments
  • Aortic Disease and Treatment Approaches
  • Neuropeptides and Animal Physiology
  • Cardiac Valve Diseases and Treatments
  • Renal and Vascular Pathologies
  • Vascular Anomalies and Treatments
  • Fluid Dynamics and Heat Transfer
  • Mechanical Circulatory Support Devices
  • Chemokine receptors and signaling
  • Cardiac Ischemia and Reperfusion
  • Infective Endocarditis Diagnosis and Management
  • Music Therapy and Health
  • Airway Management and Intubation Techniques
  • Neuroblastoma Research and Treatments
  • Adhesion, Friction, and Surface Interactions
  • Surface Modification and Superhydrophobicity
  • Pain Mechanisms and Treatments
  • Aortic aneurysm repair treatments
  • Cardiovascular and Diving-Related Complications
  • Pharmacological Effects and Toxicity Studies
  • Congenital Diaphragmatic Hernia Studies
  • Anesthesia and Sedative Agents

Nihon University
2020-2025

Shinshu University
2024

Abstract Introduction: Dysregulation of clock genes has been reported in pancreatic ductal adenocarcinoma (PDAC), but the effects dysregulation on circadian rhythm, PDAC carcinogenesis, progression and prognosis remain unclear. To investigate dysfunctional Bmal1, a major gene, we compared KPPC (LSL-KrasG12D/+; Trp53flox/flox; Pdx-1cre/+) KPPBC Bmal1flox/flox; transgenic mice with PDAC. Methods: Six-week-old were housed wheel cages, rhythms measured until humane endpoint. Tumor status plasma...

10.1158/1538-7445.am2025-6340 article EN Cancer Research 2025-04-21

Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Patients inoperative PDAC require effective chemotherapy and pain control to increase their quality of life. We investigated whether duloxetine, serotonin–noradrenaline reuptake inhibitor, improves life in KPPC ( LSL-Kras G12D/+ ;Trp53 flox/flox ;Pdx1-cre ) mouse model PDAC. Six-week-old mice were orally administered 4 mg/kg/d duloxetine (n = 12); 0.15 atipamezole, synthetic α2 adrenergic receptor...

10.1097/j.pain.0000000000001997 article EN Pain 2020-07-13

Introduction Tramadol, a weak opioid anesthetic, is used for pain management in patients with cancer, but the effects of tramadol on cancer via µ-opioid receptor are still unknown. We assessed pancreatic ductal adenocarcinoma using transgenic mice ( LSL-Kras G12D/+ ; Trp53 flox/flox Pdx-1 cre/+ ). Methods Six-week-old were orally administered 10 mg/kg/day (n=12), and 1 naltrexone (n=9), or vehicle water (n=14) until humane endpoint. Cancer-related plasma cytokine levels by mouse grimace...

10.1136/rapm-2023-104511 article EN Regional Anesthesia & Pain Medicine 2023-06-23

Biomimetic periodic structures have garnered attention due to their excellent water repellency. The normal-taper angle, which is aspects of the cross-sectional structure, important factor in achieving repellency and pressure resistance; however, underlying physical phenomenon has not been fully explained. Moreover, once a surface becomes hydrophobic, it difficult measure apparent contact angle. purpose this paper clarify taper angle that provides high under impact conditions by formulating...

10.1038/s41598-024-81778-0 article EN cc-by-nc-nd Scientific Reports 2024-12-04

Mirogabalin, a selective voltage-gated calcium channel α2δ ligand, improves peripheral neuropathic pain; however, its effects on patients with cancers including pancreatic ductal adenocarcinoma (PDAC) remain unknown. We analyzed the of mirogabalin KPPC ( LSL-KrasG12D/+; Trp53flox/flox; Pdx-1cre/+ ) mouse model PDAC. Six-week-old mice received oral (10 mg/kg/day) (n = 10) or vehicle water 14) until humane end point. Cancer-associated pain was evaluated using scores hunching and grimace scale...

10.1097/j.pain.0000000000002852 article EN Pain 2022-12-20
Coming Soon ...